T P Shakespeare - JoVE Visualize

Showing results (1-10 of 15) with videos related to

Pageof 2

Sort By:

Australasian Radiology|February 1, 1996

Unilateral facial pain and lung cancerT P Shakespeare, M J Stevens

Australasian Radiology|July 20, 2007

Is rural radiation oncology practice quality as good as the big smoke? Results of the Australian radiotherapy single machine unit trialT P Shakespeare, M Turner, A Chapman

Journal of Medical Imaging and Radiation Oncology|September 25, 2008

RANZCR 2006 peer review audit instrumentJ Toohey, T P Shakespeare, G Morgan

Journal of Medical Imaging and Radiation Oncology|September 25, 2008

Importance of daily electronic portal imaging in radiotherapyL J Bell, T P Shakespeare, A Willis

Clinical Oncology (Royal College of Radiologists (Great Britain))|October 23, 2003

Introducing the Intergroup 0116 protocol of adjuvant chemo-radiotherapy in gastric cancer into clinical practiceM F Back, S Premsenthil, C J Wynne, et al.

Lancet (London, England)|May 10, 2001

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contoursT P Shakespeare, V J Gebski, M J Veness, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 29, 2001

Difficulties using the Franco-Italian Glossary in assessing toxicity of cervical cancer treatmentT. P. Shakespeare, A. J. Ferrier, M. J. Holecek, et al.

Australasian Radiology|June 5, 2003

Hiding in the bunker: Challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreakR K Mukherjee, M F Back, J J Lu, et al.

Pathology|June 27, 1998

Intracranial epithelioid hemangioendothelioma arising at site of previously excised atypical meningiomaJ A Fryer, M T Biggs, I A Katz, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006

Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?T P Shakespeare, K H C Lim, K M Lee, et al.

Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:

Pageof 2

Australasian Radiology|February 1, 1996

Unilateral facial pain and lung cancerT P Shakespeare, M J Stevens

Australasian Radiology|July 20, 2007

Is rural radiation oncology practice quality as good as the big smoke? Results of the Australian radiotherapy single machine unit trialT P Shakespeare, M Turner, A Chapman

Journal of Medical Imaging and Radiation Oncology|September 25, 2008

RANZCR 2006 peer review audit instrumentJ Toohey, T P Shakespeare, G Morgan

Journal of Medical Imaging and Radiation Oncology|September 25, 2008

Importance of daily electronic portal imaging in radiotherapyL J Bell, T P Shakespeare, A Willis

Clinical Oncology (Royal College of Radiologists (Great Britain))|October 23, 2003

Introducing the Intergroup 0116 protocol of adjuvant chemo-radiotherapy in gastric cancer into clinical practiceM F Back, S Premsenthil, C J Wynne, et al.

Lancet (London, England)|May 10, 2001

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contoursT P Shakespeare, V J Gebski, M J Veness, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 29, 2001

Difficulties using the Franco-Italian Glossary in assessing toxicity of cervical cancer treatmentT. P. Shakespeare, A. J. Ferrier, M. J. Holecek, et al.

Australasian Radiology|June 5, 2003

Hiding in the bunker: Challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreakR K Mukherjee, M F Back, J J Lu, et al.

Pathology|June 27, 1998

Intracranial epithelioid hemangioendothelioma arising at site of previously excised atypical meningiomaJ A Fryer, M T Biggs, I A Katz, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006

Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?T P Shakespeare, K H C Lim, K M Lee, et al.

Pageof 2